Virax Biolabs(us:VRAX)
1.87
+6.86%
Updated on 2024-12-23
Open:1.70
Close:1.87
High:2.05
Low:1.69
Pre Close:1.75
Volume:382177.00
Amount:715965.31
Turnover:8.80%
Shares:4.34M
MarketCap:8.12M
About Virax Biolabs Company
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Company Name: Virax Biolabs
Company Address: 20 North Audley Street
Employees: 11
Fiscar Year: 03-31
IPO Date: 2022-07-21
Website: http://www.viraxbiolabs.com
CIK: 1885827
View all SEC Filings
About
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Address:20 North Audley Street
Website:http://www.viraxbiolabs.com
Market Movers